
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Max India Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Commitment to INR1,800 crores gross sales value annually for coming years. Key concall takeaways from Max India Ltd's Q2 FY27 earnings call — and how it ranks…
3 Nov 2026
Hikal Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Capital expenditure (Capex) in Q2 FY27 was INR 81 crores, focused on debottlenecking, inventory, regulatory upgrades, and selective capacity creation. Key…
3 Nov 2026
Camlin Fine Sciences Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Liquidity infusion of INR250 crores planned to stabilize working capital and support growth. Key concall takeaways from Camlin Fine Sciences Ltd's Q2 FY27…
3 Nov 2026
Nexus Select Trust Q2 FY27 investor presentation: Revenue & Margins | Arthneeti
Q2 FY27
Q2 FY27 Revenue from Operations: INR 675 Cr (Page 28) . Key investor presentation takeaways from Nexus Select Trust's Q2 FY27 investor presentation — and how it ranks against sector…
3 Nov 2026
Vascon Engineers Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Ambitious 4-5 year growth plan to increase sales from under INR200 crores to INR1,200-1,500 crores by FY30-31 (5x growth). Key concall takeaways from Vascon…
3 Nov 2026
Minda Corporation Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
EV product revenue is growing rapidly; accounts for about 10%-15% of current revenues and contributes ~35% of new order wins. Key concall takeaways from Minda…
3 Nov 2026
Gujarat Fluorochemicals Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Fluoropolymers business grew 22% YoY in Q2 FY'27, with confidence to sustain 17-20% annual growth over next few years driven by high-performance, specialty…
3 Nov 2026
Kopran Q2 FY27 investor presentation: Revenue & Margins | Arthneeti
Q2 FY27
9,335 lakhs (~79% increase) . Key investor presentation takeaways from Kopran Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
3 Nov 2026
Knowledge Realty Trust Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Weighted average mark-to-market rental upside of 25% across the portfolio until FY30 supports revenue growth. Key concall takeaways from Knowledge Realty…
3 Nov 2026
Bodal Chemicals Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Potential for organic and inorganic growth through brownfield expansions and selective acquisitions (~INR100-200 crore range) to maintain growth while keeping…
3 Nov 2026
RattanIndia Enterprises Q2 FY27: Revenue ₹1,974 Cr, PAT ₹84 Cr | Arthneeti
Q2 FY27
Q2 FY27 revenue: ₹1,974 crore, up from ₹1,806 crore in Q1 FY27 (sequential growth). Key investor presentation takeaways from RattanIndia Enterprises Ltd's Q2 FY27 earnings…
3 Nov 2026
AIA Engineering Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Overall margins saw a slight decline in Q2 due to elevated freight expenses, but operating EBITDA decline was limited to about 2.5-3%. Key concall takeaways…
3 Nov 2026
Solar Industries India Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Defense segment is poised for significant growth with a total defense order book of ~INR18,000 crores, including international orders and new product…
3 Nov 2026
Yatharth Hospital & Trauma Care Services Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
International business is growing steadily, with over 35% growth in H1 and increasing contribution likely in the next 3-5 years. Key concall takeaways from…
3 Nov 2026
Synergy Green Industries Q2 FY27: Order Book ₹200 Cr | Arthneeti
Q2 FY27
Synergy Green Industries has a confirmed export order book exceeding ₹200 crores with Nordex, primarily for the US market. Key concall takeaways from Synergy…
3 Nov 2026
Emcure Pharmaceuticals Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Finance cost increased to INR36 crores due to increased borrowings, primarily to fund acquisition-related payouts. Key concall takeaways from Emcure…
3 Nov 2026
Ajmera Realty & Infra India Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
and INR 7,000 crores in potential revenue. Key concall takeaways from Ajmera Realty & Infra India Ltd's Q2 FY27 earnings call — and how it ranks against sector…
3 Nov 2026
State Bank of India Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Deposits are growing robustly (12.27% YoY), supporting balance sheet growth. Key concall takeaways from State Bank of India's Q2 FY27 earnings call — and how…
3 Nov 2026
Innomet Advanced Materials Q2 FY27: Revenue ₹55.7 Cr, PAT ₹4.75 Cr | Arthneeti
Q2 FY27
Revenue for H1 FY27: ₹55.7 crore, up 137% YoY from ₹23.53 crore in H1 FY26 (Page 6). Key investor presentation takeaways from Innomet Advanced Materials Ltd's Q2 FY27…
3 Nov 2026
Bajaj Finserv Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Overall, investment needs for emerging businesses total approximately INR 800-900 crores, with additional capital for ALTs, supported by current surplus…
3 Nov 2026
Arthneeti Pro · Annual
Every earnings call this season,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access